4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001104659-19-002543
Chief Technology Officer sold 7,000 shares at an average $26.36 ($184,540)
- Chief Technology Officer acquired 7,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Myer Vickesh · Chief Technology Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-01-17 | Exercise or conversion : show line 1 in the form | +3,000 | $0.65 | $1,950 | 3,000 | D |
| 2019-01-17 | Sale : show line 2 in the form | −3,000 | $26.18 | $78,540 | 0 | D |
| 2019-01-18 | Exercise or conversion : show line 3 in the form | +4,000 | $11.21 | $44,840 | 4,000 | D |
| 2019-01-18 | Sale : show line 4 in the form | −4,000 | $26.50 | $106,000 | 0 | D |
| Open-market sales · 7,000 sh · avg $26.36 · $184,540 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-01-17 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −3,000 | 79,307 | D |
| 2019-01-18 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −4,000 | 52,897 | D |
Loading xslF345X03/a4.xml…